Crane Company (CR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Dec, 2025Executive summary
Q1 2025 net sales rose 9.3% to $557.6 million, with adjusted EPS up 24% to $1.39 and GAAP EPS up 31% to $1.34, driven by 7.5% core sales growth and 2.5% from acquisitions.
Core orders increased 15.6% and backlog grew 12.1%, led by Aerospace & Electronics, which saw sales up 10.2% to $248.9 million and a record $960.1 million backlog.
Process Flow Technologies sales rose 8.6% to $308.7 million, with 5% core growth and 5% from acquisitions; backlog stable at $389.9 million.
Completed sale of Engineered Materials segment for $208 million, resulting in a $35.7 million pre-tax gain and supporting cash flow.
Strong balance sheet with over $1.5 billion in M&A capacity, $1,235 million liquidity, and robust acquisition pipeline.
Financial highlights
Adjusted operating profit increased 17.6% to $104.1 million; operating profit up 24.4% to $101.1 million.
Adjusted operating margin improved to 18.7% from 17.3% year-over-year; adjusted EBITDA margin rose to 20.8%.
Net income from continuing operations was $78.3 million, up 33.2% year-over-year.
Cash and cash equivalents increased to $435.1 million; free cash flow was negative $58.2 million, reflecting seasonality.
Dividend per share was $0.23, up from $0.205 in the prior year.
Outlook and guidance
Full-year 2025 adjusted EPS guidance reaffirmed at $5.30–$5.60, with sales growth expected at 5% and core sales growth of 4–6%.
Adjusted segment operating profit guidance is $500–$515 million, with margin targeted at 22.5%+.
Aerospace & Electronics sales projected to grow in high single digits; Process Flow Technologies sales expected to rise 4–5%.
M&A expected to contribute 1–2% to growth; FX headwind of 1% anticipated.
Guidance assumes current tariffs and economic conditions persist, with flexibility to absorb modest demand or trade deterioration.
Latest events from Crane Company
- Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Record 2025 growth and acquisitions set up 10% adjusted EPS growth for 2026.CR
Q4 20252 Feb 2026 - Q2 sales up 14% and adjusted EPS up 18%, with raised full-year guidance and strong segment growth.CR
Q2 20242 Feb 2026 - Q3 2024 saw 13% sales growth, 34% higher EPS, and raised full-year guidance.CR
Q3 202418 Jan 2026 - Q4 adjusted EPS up 58%, sales up 12%, and 2025 guidance raised with a 12% dividend increase.CR
Q4 20249 Jan 2026 - Strong growth, margin expansion, and disciplined M&A set the stage for doubling business size.CR
Gabelli Funds 35th Annual Pump, Valve & Water Symposium7 Jan 2026 - Proxy details director elections, auditor ratification, and performance-based executive pay.CR
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting with no fee required.CR
Proxy Filing1 Dec 2025 - Q2 sales up 9.2%, adjusted EPS up 24%, guidance raised, and major PSI acquisition announced.CR
Q2 20253 Nov 2025